Thank you for your interest in this study. You will be asked a few questions to see if you qualify.

The purpose of this research is to explore your experience of living with asthma and understand your experiences with and expectations towards new treatment.

This research is being undertaken by IQVIA™, an independent research organization, on behalf of a pharmaceutical company sponsor (“sponsor”). Please note that your answers to the screening questions will help us determine your eligibility to take part in this study. 

As part of this eligibility screening, you may be asked to provide us with non-identifiable, high-level answers to questions. Please see www.iqvia.com/about-us/privacy for specific details on the types of information collected, how your information may be used, protected, and how to exercise your rights.  

By deciding to participate in this research, you agree that IQVIA must collect certain information to determine eligibility and, if eligible, collect additional information, as needed, for the research itself. All information obtained about you as part of the research will be securely stored and treated as strictly confidential by IQVIA, only accessible by authorized individuals.

There are no right or wrong answers. You will be asked a few questions that will help the study team understand whether you can take part in this study. After you have answered all questions, you will be told whether you meet the criteria and can participate in the study. More information will be shared with you about the study, after you have answered all questions. 

Any information you provide to us in this form will be treated as confidential. It will be combined with responses collected from other individuals like yourself and will be stored so that only people with permission can access the information. Personal identifying information, such as your name and contact information, will be stored securely and separately to any responses that you provide during the survey. Any personal identifying information you give in this form will be destroyed after 5 years after the end of the study. Your information will not be passed to any other organization without your permission. 

If you are eligible to take part in the study, you will be provided with a consent form, which explains what the study involves and your rights as a study participant. 

If you mention a side effect (referred to as safety information) of a medication or device, we are required to pass the details of what happened to the pharmaceutical company sponsoring the research and the relevant regulators in your country of residence (for example the FDA in the US).   

In those situations, where you mention safety information, we need to know if you are willing to waive the confidentiality given to you under the Market Research Codes of Conduct, because we will need to collect personal data.

a)    Any personal data in relation to the safety information reported will be forwarded to the project sponsor; and

b)    The project sponsor will record and retain any safety information, including personal data related to safety information, in the sponsor’s global database for as long as required, and in the interests of patient safety and in compliance with all applicable global laws and regulations; and 

c)    During the reporting of safety information, the project sponsor will not disclose such personal data to any un-associated third parties, with the exception of any disclosures required by applicable law, regulation or the order of a competent authority.

Do you agree to waive the confidentiality given to you under the Market Research Codes of Conduct in relation to any safety information you report to us? If you agree, your contact details will be forwarded to the sponsor's Safety department for the express and sole purpose of follow-up of such report(s).  Details of safety information may be reported to regulatory authorities along with your personal data. All other information provided by you in this study will remain confidential.  If you prefer to preserve the confidentiality of this information, please select 'I do not agree'. If you do so, you can still participate in this study.